Post-graduate Program in Translational Medicine, Federal University of São Paulo, São Paulo, SP, Brazil.
Laboratory of Exercise Physiology, Olympic Center of Training and Research, São Paulo, SP, Brazil.
Eur J Appl Physiol. 2019 Mar;119(3):621-632. doi: 10.1007/s00421-018-4052-3. Epub 2018 Dec 12.
High cardiac vagal control in endurance athletes has been generally associated with adequate recovery from training and readiness to cope high-intensity training. A method that improves cardiac vagal control in endurance athletes could therefore be advantageous. Accordingly, we sought to test whether ischemic preconditioning (IPC) could enhance cardiac vagal control in endurance runners.
Fifteen subjects underwent IPC, sham ultrasound (SHAM) or control (CT), in random order. Subjects were informed both IPC and SHAM would be beneficial vs. CT (i.e., similar placebo induction), and IPC would be harmless despite ischemia sensations (i.e., nocebo avoidance). Resting cardiac vagal control was assessed via respiratory sinus arrhythmia (RSA) and heart rate variability (HRV) indexes. Post-exercise cardiac vagal control was assessed via heart rate recovery [HR time constant decay (T30) and absolute HR decay (HRR30s)] during 30-s breaks of a discontinuous incremental test. Capillary blood samples were collected for lactate threshold identification.
RSA and HRV were similar among interventions at pre- and post-intervention assessments. Lactate threshold occurred at 85 ± 4% of maximal effort. T30 was similar among interventions, but IPC increased HRR30s at 70% and 75% of maximal effort vs. SHAM and CT (70%: IPC = 31 ± 2 vs. SHAM = 26 ± 3 vs. CT = 26 ± 2 bpm, mean ± SEM, P < 0.01; 75%: IPC = 29 ± 2 vs. SHAM = 25 ± 2 vs. CT = 24 ± 2 bpm, P < 0.01).
IPC did not change resting cardiac vagal control, but boosted fast post-exercise cardiac vagal reactivation at exercise intensities below lactate threshold in endurance runners.
在耐力运动员中,较高的心脏迷走神经控制通常与从训练中充分恢复和应对高强度训练的能力有关。因此,提高耐力运动员心脏迷走神经控制的方法可能是有利的。相应地,我们试图测试缺血预处理(IPC)是否可以增强耐力跑步者的心脏迷走神经控制。
15 名受试者随机接受 IPC、假超声(SHAM)或对照(CT)处理。受试者被告知 IPC 和 SHAM 都将比 CT 有益(即类似的安慰剂诱导),尽管存在缺血感觉,但 IPC 是无害的(即避免无效反应)。通过呼吸窦性心律失常(RSA)和心率变异性(HRV)指标评估静息时心脏迷走神经控制。通过在不连续递增测试的 30 秒休息期间评估心率恢复[心率时间常数衰减(T30)和绝对心率衰减(HRR30s)]来评估运动后心脏迷走神经控制。采集毛细血管血样以确定乳酸阈。
在干预前后的评估中,RSA 和 HRV 在各干预组之间相似。乳酸阈出现在最大努力的 85±4%。T30 在各干预组之间相似,但与 SHAM 和 CT 相比,IPC 增加了 70%和 75%最大努力时的 HRR30s(70%:IPC=31±2 比 SHAM=26±3 比 CT=26±2 bpm,平均值±SEM,P<0.01;75%:IPC=29±2 比 SHAM=25±2 比 CT=24±2 bpm,P<0.01)。
IPC 并未改变静息时的心脏迷走神经控制,但在耐力跑步者的运动强度低于乳酸阈时,加速了运动后心脏迷走神经的快速再激活。